Ken Griffin started the Citadel hedge fund in 1990. In the third quarter, Griffin and Citadel more than tripled its stake in Viking Therapeutics (NASDAQ: VKTX). Wall Street analysts are sticking their necks out and predicting big gains around the corner.

The chatter on Wall Street has been about a nominee for treasury secretary — plenty of donors and advisors, helped by their surrogates, are battling for the nod. A name that has recently gotten traction is Apollo CEO Marc Rowan, whom Trump interviewed at his Florida home this week.

Ken Griffin said he would consider selling a piece of Citadel, the $65 billion multistrategy hedge fund he founded in 1990.

Microsoft is a major player in AI through its partnership with OpenAI and its Azure Cloud infrastructure. Citadel sold much of its Microsoft shares earlier this year, amid broader shifts in its investing strategy.

Ken Griffin urged Trump to moderate immigration and inflation policies, warned tax cuts risk debt, and is open to selling a minority stake in Citadel.

Citadel's founder Ken Griffin said on Thursday that he would be open to selling a small stake in his hedge fund at some point in the future. Griffin, at an event hosted by the Economic Club of New York,

Citadel Advisors, run by billionaire investor Ken Griffin, is one of the most prestigious hedge funds on Wall Street, and while reviewing the 13F it filed on Nov. 14, I noticed something. In the third quarter, the fund increased its stake by 172% in a semiconductor stock that isn't Nvidia.

Griffin has been happy with how Sequoia, which is a minority shareholder in Citadel Securities, has helped his market maker.

Ken Griffin is arguably one of the most successful investors of all time. He made a name for himself when he shorted stocks just ahead of the 1987 market crash that came to be known as "Black Monday." His profits last year topped $7 billion as his returns of roughly 15% outpaced many of his peers.